Le Lézard
Classified in: Health
Subjects: PDT, MAT

Lab Effects Introduces The Future of Cannabis-Derived Terpenes


GOLDEN, Colo., July 30, 2020 /PRNewswire/ -- Lab Effects, the leader in profiling, extraction, and custom formulation of botanical and cannabis terpenes, announced the launch of their full line of Cannabis Hybrid Terpenestm, which combine cannabis-derived and botanical terpenes. Now, cannabis, food, and beverage product manufacturers can cost-effectively integrate any cannabis strain's authentic aroma into their product lines.

"We're thrilled to introduce Cannabis Hybrid Terpenestm to the market," said Scott Holden, CEO, and founder of Lab Effects. "The proverbial "holy grail" of the terpene industry has always been the pursuit of capturing the non-terpene elements responsible for the cannabis flower's most essential aromas. We have completed this task and can now replicate any cannabis strain's actual smell, not just the gassy botanical notes provided by profile matching with other plant-derived terpenes."

This newest innovation was developed by Lab Effects with a carefully selected suite of cannabis-derived essential oil bases, which represent the most ubiquitous cannabis aroma categories of diesel, fruity, skunky, earthy, and floral. Running analytics on cannabis flower genetics allows Lab Effects to map out the exact terpene spectrum of a particular strain. They use this data to fortify each cannabis-derived base with its correlated strain-specific profile made from other botanical terpenes at carefully chosen ratios, so every base aromatic note of that variety is captured and expressed.

This arrives when cannabis-derived terpenes are highly sought after for flavoring products intended to smell just like the plant in its natural form but come with challenges such as limited supply options, availability, cost, standardization, and scalability. These factors have driven manufacturers to pull terpenes from other plant sources. However, non-cannabis botanicals will never emit the key elements that are inherent to the cannabis plant's essential oils.

"Cannabis Hybrid Terpenestm solve all the historical challenges associated with both cannabis-derived terpenes and botanical terpene blends," said Holden. "By using botanical source profiles, we ensure that no actual terpenes are missing from the fraction, which is common due to variable changes from batch to batch. Similarly, botanical terpene blends lack the essential oil aspects of cannabis-derived terpenes, which provide that unique essence of a cannabis aroma. By carefully combining these two, we produce a product that provides the best of both worlds."

With Lab Effects' line of Cannabis Hybrid Terpenestm, manufacturers can control costs, scale, and standardize products while ensuring end-consumers experience every note and nuance of a cannabis strain's true aroma in a product. The laboratory can replicate any desired cannabis strain for its clients at more than half of what a cannabis-derived product typically costs. They are available in both water-soluble and oil-soluble formats, as well as high-speed flowable powders.

About Lab Effects:

Lab Effects is the premier and trusted source for botanical profiling, extraction, purification, and custom formulation of 100% natural terpenes. More information can be found on www.labeffects.com. Sales inquiries can be made via telephone at 720.524.6369.

Contact:

Contact: Emma Bisogno
Phone: 720 524 6369
Email: [email protected]

SOURCE Lab Effects


These press releases may also interest you

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...

at 19:29
Suffolk DBT is proud to announce the completion of their initial expansion to accommodate the growing need for DBT therapy...

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...



News published on and distributed by: